Absci Corporation (ABSI)
NASDAQ: ABSI · Real-Time Price · USD
3.820
+0.080 (2.14%)
At close: Jan 30, 2025, 4:00 PM
3.800
-0.020 (-0.52%)
After-hours: Jan 30, 2025, 5:41 PM EST
Absci Revenue
Absci had revenue of $1.70M in the quarter ending September 30, 2024, with 128.63% growth. This brings the company's revenue in the last twelve months to $4.21M, down -39.35% year-over-year. In the year 2023, Absci had annual revenue of $5.72M, down -0.50%.
Revenue (ttm)
$4.21M
Revenue Growth
-39.35%
P/S Ratio
95.02
Revenue / Employee
$27,142
Employees
155
Market Cap
438.75M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 5.72M | -29.00K | -0.50% |
Dec 31, 2022 | 5.75M | 965.00K | 20.18% |
Dec 31, 2021 | 4.78M | 2.00K | 0.04% |
Dec 31, 2020 | 4.78M | 2.72M | 132.04% |
Dec 31, 2019 | 2.06M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 63.17B |
AbbVie | 55.53B |
AstraZeneca | 51.21B |
Novartis AG | 49.94B |
Thermo Fisher Scientific | 42.37B |
Abbott Laboratories | 41.95B |
ABSI News
- 8 days ago - Analyst Praises AMD-Partner Absci's Practical Approach, Sees 118% Stock Upside - Benzinga
- 8 days ago - Absci to Participate in the Guggenheim Securities SMID Cap Biotech Conference - GlobeNewsWire
- 17 days ago - Absci Looks Cheap And Positioned For Growth With AMD's AI Backing - Seeking Alpha
- 20 days ago - Absci and Owkin Synergize Leading TechBio Platforms to Advance Generative AI Drug Discovery - GlobeNewsWire
- 22 days ago - Absci and AMD Announce Collaboration and Strategic Investment to Accelerate the Future of AI Drug Discovery - GlobeNewsWire
- 24 days ago - Absci and Invetx Partner to Bring Generative AI Drug Creation Platform to Animal Health - GlobeNewsWire
- 2 months ago - Absci Corporation (ABSI) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Absci Reports Business Updates and Third Quarter 2024 Financial and Operating Results - GlobeNewsWire